Participants 96 158 7
elderly adults with newly diagnosed acute myelogenous leukemia
Participants 204 272 4
elderly adults with newly diagnosed acute myelogenous leukemia (AML)
Participants 452 558 6
84 adults (age range, 70-90 years; median, 76 years) who were not candidates for conventional chemotherapy
